Ensuring Viral Clearance and Safety in Biologics
30 November - 1 December 2010
Munich, Germany
Contaminations in both Baxter and Genzyme biological products in 2009, and the porcine circovirus contamination of GSK’s Rotarix vaccine in March of this year have highlighted the issue of viral safety in biologics more than ever before. More>> |